Transaction · 0000950170-25-002439

Robb Gary Charles

Robb Gary Charles, CBO, reported an open-market or private sale at CORCEPT THERAPEUTICS INC involving 11000.000000 shares for an estimated $555551.70. Reported holdings after the transaction were 20119.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCBO
CORTCORCEPT THERAPEUTICS INC
Filing timeJan 07
Trade dateJan 02, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

CORT price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
CORT since 2025-01-07Filed 605 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0000950170-25-002439
Common Stock
Transaction date
Jan 02, 2025
Filed Jan 07, 2025, 12:15 AM · 5d delay
Shares
11.0k sh
$5.05k per share
Estimated value
-$55.5M
Computed from shares × price
Holdings after
20.1k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Large Holdings Reduction 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Business Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Includes 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,818 shares underlying unvested restricted stock awards granted to the…

  2. F2

    This transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction.

  3. F3

    Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $50.39 to $50.84 per share. Information on the exact number of shares sold at each sa…

  4. F4

    These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.

  5. F5

    Fully exercisable.

Original filing · 0000950170-25-002439
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

CORT